TPO and autoimmune thrombocytopenic purpura: TPO-RAs such as eltrombopag are associated with an increased risk of thromboembolism (GlaxonSmithKline, 2015), on top of the increased risk of thromboembolic events seen in elderly patients with ITP [10].